within Pharmacolibrary.Drugs.D_Dermatologicals.D07C_CorticosteroidsCombinationsWithAntibiotics.D07CA03_PrednisoloneAndAntibiotics;

model PrednisoloneAndAntibiotics
  extends Pharmacolibrary.Drugs.ATC.D.D07CA03;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>D07CA03</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Prednisolone is a synthetic glucocorticoid with anti-inflammatory and immunosuppressive properties, often used for skin disorders. This ATC code (D07CA03) refers to prednisolone and antibiotics combined, typically formulated as topical preparations for the treatment of inflammatory skin disorders complicated by bacterial infection. These combination products are approved for topical use in various countries.</p><h4>Pharmacokinetics</h4><p>No primary literature or pharmacokinetic studies specifically describe PK parameters for the topical combination of prednisolone and antibiotics (ATC D07CA03)—parameters estimated based on topical prednisolone data where absorption is limited and systemic exposure is generally low in healthy adults.</p><h4>References</h4><ol><li><p>Moksha, L, et al., &amp; Velpandian, T (2021). Pharmacoproteomic analysis of topical dapsone and prednisolone interventions in the aqueous humor of anterior uveitis. <i>Experimental eye research</i> 206 108534–None. DOI:<a href=&quot;https://doi.org/10.1016/j.exer.2021.108534&quot;>10.1016/j.exer.2021.108534</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33722510/&quot;>https://pubmed.ncbi.nlm.nih.gov/33722510</a></p></li><li><p>Klotz, U (1985). Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid. <i>Clinical pharmacokinetics</i> 10(4) 285–302. DOI:<a href=&quot;https://doi.org/10.2165/00003088-198510040-00001&quot;>10.2165/00003088-198510040-00001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2864155/&quot;>https://pubmed.ncbi.nlm.nih.gov/2864155</a></p></li><li><p>Johansen, S, et al., &amp; Prause, JU (1996). A bioavailability comparison in rabbits after a single topical ocular application of prednisolone acetate formulated as a high-viscosity gel and as an aqueous suspension. <i>Acta ophthalmologica Scandinavica</i> 74(3) 253–258. DOI:<a href=&quot;https://doi.org/10.1111/j.1600-0420.1996.tb00087.x&quot;>10.1111/j.1600-0420.1996.tb00087.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8828722/&quot;>https://pubmed.ncbi.nlm.nih.gov/8828722</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end PrednisoloneAndAntibiotics;
